Publication | Closed Access
Factors Influencing Time to Determination of the Recommended Phase 2 Dose in Phase 1 Clinical Trials
25
Citations
7
References
2012
Year
Including a predefined phase 2 dose and reducing the number of dose levels and expansion cohorts may shorten phase 1 trial TDR.
| Year | Citations | |
|---|---|---|
Page 1
Page 1